Skip to main content
OpenTrials

Clinical trial condition

Psychomotor Disorders

Explore clinical trials studying Psychomotor Disorders. Study availability and eligibility vary by location and protocol.

270 public trials 37 recruiting studies
Refine in advanced search Browse all conditions

Psychomotor Disorders trial results

Completed

Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder

NCT04276883

Conditions
Aberrant Motor Behavior in Dementia, Agitation Associated With Bipolar Disorder, Agitation,Psychomotor, +14 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Culver City, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View all 15 locations
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY II)

NCT05271552

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +14 more
Locations
  • BioXcel Clinical Research Site Phoenix, Arizona, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
  • BioXcel Clinical Research Site Daytona Beach, Florida, United States
  • BioXcel Clinical Research Site Lady Lake, Florida, United States
View Trial Details
Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Schizophrenia

NCT04010305

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +12 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Lemon Grove, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia

NCT04268303

Conditions
Aberrant Motor Behavior in Dementia, Agitation, Behavior, +16 more
Locations
  • BioXcel Clinical Research Site Little Rock, Arkansas, United States
  • BioXcel Clinical Research Site Cerritos, California, United States
  • BioXcel Clinical Research Site Culver City, California, United States
  • BioXcel Clinical Research Site Long Beach, California, United States
View all 15 locations
View Trial Details
Completed

Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia

NCT04251910

Conditions
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor, Behavior, +14 more
Locations
  • BioXcel Clinical Research Site Homestead, Florida, United States
  • BioXcel Clinical Research Site Miami Lakes, Florida, United States
  • BioXcel Clinical Research Site Springfield, Massachusetts, United States
  • BioXcel Clinical Research Site Caro, Michigan, United States
View Trial Details
Completed

Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)

NCT05658510

Conditions
Aberrant Motor Behavior in Dementia, Agitation,Psychomotor, Behavior, +20 more
Locations
  • BioXcel Clinical Research Site 113 Bellflower, California, United States
  • BioXcel Clinical Research Site 128 Cerritos, California, United States
  • BioXcel Clinical Research Site 110 Culver City, California, United States
  • BioXcel Clinical Research Site 108 Garden Grove, California, United States
View all 24 locations
View Trial Details
Completed

Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder

NCT07116694

Conditions
Aberrant Motor Behavior in Dementia, Behavior, Behavioral Symptoms, +19 more
Locations
  • BioXcel Clinical Research Site 103 Chino, California, United States
  • BioXcel Clinical Research Site 105 Oceanside, California, United States
  • BioXcel Clinical Research Site 102 Orange, California, United States
  • BioXcel Clinical Research Site 101 St Louis, Missouri, United States
View Trial Details

Related conditions